Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan Kensei Tobinai Pages: S85 - S90
Histone deacetylase as a new target for cancer chemotherapy Minoru YoshidaRyohei FurumaiSueharu Horinouchi Pages: S20 - S26
Phosphatidyl inositol signaling by BCR/ABL: opportunities for drug development James D. Griffin Pages: S11 - S16
Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins Scott W. HiebertBart LutterbachYue Hou Pages: S31 - S34
Evaluating the contribution of allogeneic and autologous transplantation to the management of acute myeloid leukemia in adults Alan K. Burnett Pages: S53 - S58
STI571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy Michael J. MauroMichael E. O'DwyerBrian J. Druker Pages: S77 - S78
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG) Norio AsouKoichi AdachiRyuzo Ohno Pages: S65 - S71
Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma Thomas E. Witzig Pages: S91 - S95
Transport of intracellularly active ribozymes to the cytoplasm Makoto MiyagishiTomoko KuwabaraKazunari Taira Pages: S96 - S101
Histone deacetylases and transcriptional therapy with their inhibitors Pier Pandolfi Original Article Pages: S17 - S19
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy Tomoki NaoeHitoshi KiyoiHidehiko Saito Pages: S27 - S30
Remission induction therapy: the more intensive the better? Thomas BüchnerWolfgang HiddemannAchim Heinecke Original Article Pages: S41 - S44
Multicenter prospective study of interferon-α versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis Kazunori OhnishiTeruo InoRyuzo Ohno Pages: S59 - S64
Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals Shimon SlavinReuven OrArnon Nagler Pages: S79 - S84
New strategies for cancer therapy in the 21st century Nagahiro SaijoTomohide TamuraKazuto Nishio Pages: S102 - S106
Acute myeloid leukemia in adults: where do we go from here? Charles A. Schiffer Original Article Pages: S45 - S52